Beginning four years ago, 15 women with incurable (metastatic triple-negative) breast cancer were enrolled in a unique clinical trial. It explored one concept of “precision medicine” – the suggestion that the brain power of multiple medical experts and the collection of an immense volume of data about each woman’s condition would yield the most personalized, customized care possible. Read More
32 researchers at 14 institutions joined to identify personalized treatment options for woman with metastatic triple-negative breast cancer A new report documents one cancer patient’s experience with an unprecedented level of individualized care, provided […] Read More
Trial enrollees sought; effort involves sharing tumors’ responses to therapy in massive public online database. Ten women with advanced breast cancer will participate in one of the most intensive clinical trials ever […] Read More